View of Clinical efficacy of the symbiotic drug Lotardi-A in the complex therapy of patients with irritable bowel syndrome in metabolic-associated fatty liver disease

Return to Article Details Clinical efficacy of the symbiotic drug Lotardi-A in the complex therapy of patients with irritable bowel syndrome in metabolic-associated fatty liver disease Download Download PDF